WebMar 11, 2024 · In 2024, governments and healthcare systems spent US$36.9 billion on Pfizer’s COVID-19 vaccine Comirnaty (tozinameran), making it the best-selling drug of the year and catapulting Pfizer to the ... WebApr 13, 2024 · Biotech companies have largely fended off a buying frenzy from Big Pharma following peak valuations in early 2024, but Silicon Valley Bank’s collapse may leave many small and midsize companies vulnerable to acquisition. Nearly half of US biotech companies banked with SVB prior to the collapse, reported KQED, and experts say these companies ...
Two-Component Recombinant COVID-19 Vaccine ReCOV Granted …
WebSep 10, 2024 · Pfizer announced that it was starting its phase 3 clinical trial for its respiratory syncytial virus vaccine candidate, known as RSVpreF. If phase 3 clinical results come close to replicating... WebOct 28, 2024 · Our core product REC603, a recombinant 9-valent HPV vaccine in Phase III clinical trial, shows great promise of becoming the first marketed domestic 9-valent HPV vaccine. Apart from that, ReCOV, a recombinant COVID-19 vaccine with its commercialization in the offing, has been recognized as one of the most competitive next … how to take wonderlic test
Pfizer is on the hunt for new blockbuster drugs, backed by its …
Web48 minutes ago · In 2024, the pharmaceutical giant raked in $100 billion in revenue -- $57 billion of which came from its COVID-19 vaccine Comirnaty, and its COVID-19 antiviral therapy, Paxlovid -- and $31 billion ... WebFeb 13, 2024 · Staying true to the mission of "Protect human health with best-in-class vaccines", the Company has established high-value pipelines consisting of several blockbuster vaccines with proprietary... WebSep 10, 2024 · There's a real possibility that Pfizer could have yet another megablockbuster vaccine on its hands within the next few years. And Pfizer won't stop there. The … reagan williams obituary 2022